English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 903910      Online Users : 703
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/4720


    Title: TGF-beta-induced Stat3 phosphorylation mediated growth regulation in lungi cancer
    Authors: Tseng, SW;Chen, KL;Ho, BY;Shih, NY
    Contributors: National Institute of Cancer Research
    Abstract: Background: Transforming growth factor-beta (TGFβ) is a well-known potent growth inhibitor for many tumor cells of epithelial origin. Loss of response to TGFβ-mediated growth inhibition is frequently associated with malignant progression in a variety of human cancers. However, during anticancer chemotherapy, tumor cells often develop a coordinate resistant to that drug and cytotoxic cytokines. Recent study has revealed the cross-resistance of adriamycin and TGFβ in tumor cells. However, no distinct mechanisms have been proposed. Thus, this study tried to dissect the relationship between acquisition of drug resistant of tumor cells and subsequent acquisition of resistance to TGFβ. Materials and methods: NCI-H23 parental (H23P) and NCI-H23 adriamycin resistant (H23ADR) lung adenocarcinoma cell lines were used in this study. The variations of biological functions induced by TGFI3 in these two cell lines were studied by cell proliferation assays, flow cytometric analyses, transcription reporter assays, and Western blotting. Results: We demonstrated that, after TGFβ1 treatment, H23ADR cells are much more refractory to TGFβ-mediated growth suppression than their parental (H23P) cells. The action is not either attributed to differential expression of TGFβ receptors, or involved in TGFβ1-induced cell cycle arrest and cell death between these two cell lines. By comparison studies on differential activations of TGF[Mnduced signaling molecules, we first demonstrate that TGFβ1 can augment endogenous Stat3 activity in H23P cells with slow kinetics, but barely affects on H23ADR cells. Transfection of constitutively active Stat3 into H23ADR cells led to growth suppression in the absence of TGFβ1 ; additionally, expression of dominant-negative Stat3 significantly rescued H23P cells from TGFβ1-mediated growth suppression. Conclusion: Our data suggest that modulation of Stat3 activity play a critical role in the TGFβ1-regulated cell growth during acquired adriamycin resistance, and provide the first evidence that Stat3 activity is involved in the cell growth suppression elicited by TGFβ1 in cancer cells.
    Date: 2005-10
    Relation: EJC Supplements. 2005 Oct;3(2):52.
    Link to: http://dx.doi.org/10.1016/S1359-6349(05)80481-1
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000247564800163
    Appears in Collections:[施能耀] 會議論文/會議摘要
    [曾思文(1997-2007)] 會議論文/會議摘要

    Files in This Item:

    File Description SizeFormat
    ISI000247564800163.pdf143KbAdobe PDF616View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback